查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1772208

美國呼吸器和麻醉面罩市場規模、佔有率和趨勢分析報告：按面罩類型、應用和細分市場預測，2025-2030 年

U.S. Artificial Ventilation And Anesthesia Masks Market Size, Share & Trends Analysis Report By Mask Type (Disposable Masks, Reusable Masks), By Application (Operating Rooms, ICU, Emergency Rooms, Homecare, ASCs), And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10個工作天內

價格

美國人工呼吸和麻醉面罩市場規模與趨勢

預計 2024 年美國呼吸和麻醉面罩市場規模將達到 5.527 億美元，2025 年至 2030 年的複合年成長率為 4.7%。

這種成長歸因於呼吸系統疾病發生率的上升、技術的發展、外科手術數量的增加、人口成長（尤其是老年人口）、COVID-19 大流行的影響、醫療支出的增加以及政策支持。

慢性阻塞性肺病 (COPD)、氣喘和肺炎等慢性呼吸系統疾病的盛行率不斷上升，將推動市場成長。根據美國疾病管制與預防中心 (CDC) 2024 年 6 月的一份報告，約有 600 萬美國成年人患有 COPD，COPD 是美國十大死因之一，這為醫療保健提供者和製造商投資呼吸照護解決方案創造了巨大的機會。此外，成人和兒童對長期居家照護和肺部疾病急性治療的需求不斷成長，也推動了市場需求的成長。

科技的進步使得呼吸和麻醉面罩更加易於使用且更有效率。諸如拋棄式整合監控系統、改進的面罩設計（可提高患者舒適度）以及增強的安全性能等特性，正吸引醫療保健提供者選擇這些產品。此外，隨著對優質呼吸照護解決方案的需求不斷成長，製造商正在加大研發投入，以打造創新產品，滿足醫療保健專業人員不斷變化的需求。呼吸和麻醉面罩市場注重患者的舒適度、安全性和有效性，未來幾年將迎來顯著成長。

新冠疫情對美國呼吸和麻醉面罩市場造成了重大衝擊，由於嚴重呼吸系統併發症的發生率高，呼吸支援設備的需求激增。醫院和急診室面臨人工呼吸器及相關耗材（包括口罩）的嚴重短缺，促使其迅速擴大生產規模並獲得美國食品藥物管理局（FDA）的緊急使用授權。這場危機加速了一次性口罩的普及，以降低交叉污染的風險，並刺激了非侵入性呼吸技術的創新。此外，供應鏈中斷和原料短缺暴露了脆弱性，導致疫情後國內生產力度加大，並採取了囤貨策略。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章市場變數、趨勢和範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 商業環境分析
    • 波特五力分析
    • PESTLE分析
    • 定價分析
    • COVID-19的影響

第4章。美國呼吸器和麻醉面罩市場類型、估計和趨勢分析

  • 細分儀表板
  • 美國呼吸器與麻醉面罩市場：類型變化分析，百萬美元，2024 年與 2030 年
  • 一次性口罩
  • 可重複使用的口罩

第5章美國呼吸器和麻醉面罩市場的應用、預測和趨勢分析

  • 細分儀表板
  • 美國呼吸器和麻醉面罩市場：2024 年和 2030 年應用趨勢分析
  • 手術室
  • 加護病房
  • 急診室
  • 居家醫療
  • ASC

第6章 競爭態勢

  • 參與者概覽
  • 2024年企業市場地位/佔有率分析
  • 公司分類
  • 公司簡介/上市公司
    • Medtronic
    • BD（Becton, Dickinson and Company）
    • ResMed
    • Vyaire Medical, Inc.
    • Dragerwerk AG & Co. KGaA
    • Koninklijke Philips NV
    • Nihon Kohden Corporation
    • Hamilton Medical
    • IBM
    • Ambu A/S
    • Cardinal Health
Product Code: GVR-4-68040-637-4

U.S. Artificial Ventilation And Anesthesia Masks Market Size & Trends:

The U.S. artificial ventilation and anesthesia masks market size was estimated at USD 552.7 million in 2024 and is projected to grow at a CAGR of 4.7% from 2025 to 2030. The growth can be attributed to the rising incidences of respiratory diseases, development in technology, rising number of surgeries, population growth, especially of the geriatric people, effects of the covid-19 pandemic, increased healthcare spending, and support in the policies.

The rising prevalence of chronic respiratory diseases such as COPD, asthma, and pneumonia will drive market growth. According to the CDC report of June 2024, around 6 million adults in the U.S. have COPD, and it is one of the top 10 causes of death in the U.S., presenting a significant opportunity for healthcare providers and manufacturers to invest in respiratory care solutions. The increasing demand for long-term home care and emergency treatment for lung diseases in adults and children will also contribute to market demand.

Advancements in technology have led to the development of more user-friendly and efficient artificial ventilation and anesthesia masks. Features such as integrated monitoring systems for disposables, improved mask designs for enhanced patient comfort, and enhanced safety features are attracting healthcare providers to these products. Moreover, as the demand for high-quality respiratory care solutions increases, manufacturers are investing in research and development to create innovative products that meet the evolving needs of healthcare professionals. With a focus on patient comfort, safety, and efficacy, the artificial ventilation and anesthesia masks market is poised for significant growth in the coming years.

The COVID-19 pandemic greatly impacted the U.S. artificial ventilation and anesthesia masks market, driving a surge in demand for respiratory support equipment due to the high incidence of severe respiratory complications. Hospitals and emergency departments faced acute shortages of ventilators and associated consumables, including masks, prompting rapid production scale-ups and emergency use authorizations by the FDA. The crisis accelerated the adoption of single-use and disposable masks to reduce cross-contamination risks and spurred innovations in non-invasive ventilation technologies. Additionally, supply chain disruptions and raw material shortages exposed vulnerabilities, leading to increased domestic manufacturing initiatives and stockpiling strategies post-pandemic.

U.S. Artificial Ventilation And Anesthesia Masks Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. artificial ventilation and anesthesia masks market report based on mask type and application:

  • Mask Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Disposable Masks
  • Reusable Masks
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Operating Rooms
  • ICU
  • Emergency Rooms
  • Home Care
  • ASCs

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Application
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing number of surgical procedures across hospitals and ambulatory centers
      • 3.2.1.2. Growing prevalence of respiratory disorders
      • 3.2.1.3. Technological advancements in mask materials, ergonomics, and integration with monitoring systems are enhancing product safety and comfort.
      • 3.2.1.4. Increased focus on patient safety and infection control
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Availability of alternative solutions
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenges Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal landscape
    • 3.3.3. Pricing Analysis
    • 3.3.4. Impact of COVID 19

Chapter 4. U.S. Artificial Ventilation and Anesthesia Masks Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Artificial Ventilation and Anesthesia Masks Market: Type Movement Analysis, USD Million, 2024 & 2030
  • 4.3. Disposable Masks
    • 4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Reusable Masks
    • 4.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Artificial Ventilation and Anesthesia Masks Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Artificial Ventilation and Anesthesia Masks Market: Application Movement Analysis, 2024 & 2030
  • 5.3. Operating Rooms
    • 5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. ICU
    • 5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Emergency Rooms
    • 5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Homecare
    • 5.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. ASCs
    • 5.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Participant Overview
  • 6.2. Company Market Position/Share Analysis, 2024
  • 6.3. Company Categorization
  • 6.4. Company Profiles/Listing
    • 6.4.1. Medtronic
      • 6.4.1.1. Overview
      • 6.4.1.2. Financial performance
      • 6.4.1.3. Product benchmarking
      • 6.4.1.4. Strategic initiatives
    • 6.4.2. BD (Becton, Dickinson and Company)
      • 6.4.2.1. Overview
      • 6.4.2.2. Financial performance
      • 6.4.2.3. Product benchmarking
      • 6.4.2.4. Strategic initiatives
    • 6.4.3. ResMed
      • 6.4.3.1. Overview
      • 6.4.3.2. Financial performance
      • 6.4.3.3. Product benchmarking
      • 6.4.3.4. Strategic initiatives
    • 6.4.4. Vyaire Medical, Inc.
      • 6.4.4.1. Overview
      • 6.4.4.2. Financial performance
      • 6.4.4.3. Product benchmarking
      • 6.4.4.4. Strategic initiatives
    • 6.4.5. Dragerwerk AG & Co. KGaA
      • 6.4.5.1. Overview
      • 6.4.5.2. Financial performance
      • 6.4.5.3. Product benchmarking
      • 6.4.5.4. Strategic initiatives
    • 6.4.6. Koninklijke Philips N.V.
      • 6.4.6.1. Overview
      • 6.4.6.2. Financial performance
      • 6.4.6.3. Product benchmarking
      • 6.4.6.4. Strategic initiatives
    • 6.4.7. Nihon Kohden Corporation
      • 6.4.7.1. Overview
      • 6.4.7.2. Financial performance
      • 6.4.7.3. Product benchmarking
      • 6.4.7.4. Strategic initiatives
    • 6.4.8. Hamilton Medical
      • 6.4.8.1. Overview
      • 6.4.8.2. Financial performance
      • 6.4.8.3. Product benchmarking
      • 6.4.8.4. Strategic initiatives
    • 6.4.9. IBM
      • 6.4.9.1. Overview
      • 6.4.9.2. Financial performance
      • 6.4.9.3. Product benchmarking
      • 6.4.9.4. Strategic initiatives
    • 6.4.10. Ambu A/S
      • 6.4.10.1. Overview
      • 6.4.10.2. Financial performance
      • 6.4.10.3. Product benchmarking
      • 6.4.10.4. Strategic initiatives
    • 6.4.11. Cardinal Health
      • 6.4.11.1. Overview
      • 6.4.11.2. Financial performance
      • 6.4.11.3. Product benchmarking
      • 6.4.11.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. artificial ventilation and anesthesia masks market, Type, 2018 - 2030 (USD Million)
  • Table 4 U.S. artificial ventilation and anesthesia masks market, by Application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market segmentation
  • Fig. 8 Market snapshot
  • Fig. 9 Segment snapshot
  • Fig. 10 Competitive landscape snapshot
  • Fig. 11 Market trends & outlook
  • Fig. 12 Market driver relevance analysis (current & future impact)
  • Fig. 13 Market restraint relevance analysis (current & future impact)
  • Fig. 14 PESTLE analysis
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 U.S. artificial ventilation and anesthesia masks market Type Outlook: Key Takeaways
  • Fig. 17 U.S. artificial ventilation and anesthesia masks market: type movement analysis, 2018 & 2030
  • Fig. 18 Disposable masks market estimates and forecasts 2018 - 2030 (USD Million)
  • Fig. 19 Reusable masks market estimates and forecasts 2018 - 2030 (USD Million)
  • Fig. 20 U.S. artificial ventilation and anesthesia masks market application outlook: Key takeaways
  • Fig. 21 U.S. artificial ventilation and anesthesia masks market: application movement analysis, 2018 & 2030 (USD Million)
  • Fig. 22 Operating Rooms market estimates and forecasts 2018 - 2030 (USD Million)
  • Fig. 23 ICU market estimates and forecasts 2018 - 2030 (USD Million)
  • Fig. 24 Emergency rooms market estimates and forecasts 2018 - 2030 (USD Million)
  • Fig. 25 Home care market estimates and forecasts 2018 - 2030 (USD Million)
  • Fig. 26 ASCs market estimates and forecasts 2018 - 2030 (USD Million)
  • Fig. 27 Market Participant Categorization
  • Fig. 28 Strategy mapping
  • Fig. 29 Company market position analysis